Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.

Blood 2011 Sep 15;118(10):2821-6. Epub 2011 Jul 15.

Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.

Free light chains (FLCs) are the most commonly detected paraproteins in chronic lymphocytic leukemia (CLL). We examined the types of FLC abnormalities and prognostic utility of the FLC assay compared with standard prognostic biomarkers in a prospective cohort of 339 patients with newly diagnosed CLL. Three types of FLC abnormalities were identified: monoclonal elevated FLC (elevated κ and/or λ with abnormal FLC ratio), polyclonal elevated FLC (elevated κ and/or λ with normal FLC ratio), and ratio-only FLC abnormality (normal range κ and λ with abnormal FLC ratio). One hundred sixty-five patients (49%) had a FLC abnormality with approximately equal distribution among monoclonal elevation, polyclonal elevation, and ratio-only abnormality. All FLC abnormalities were associated with poor time to first treatment: monoclonal FLC (hazard ratio [HR], 4.99; 95% confidence interval [CI], 2.94-8.48), polyclonal FLC (HR, 2.40; 95% CI, 1.24-4.64), ratio-only FLC (HR, 2.57; 95% CI, 1.40-4.69). Monoclonal FLC and polyclonal FLC were associated with poor overall survival compared with patients with normal FLC. Results remained significant after adjusting for Rai stage. The FLC assay is a simple, widely available clinical test with similar prognostic utility as routinely used prognostic biomarkers for CLL. Among persons with FLC abnormalities, the type of abnormality affects prognostic significance.

Download full-text PDF

Source
http://www.bloodjournal.org/content/118/10/2821.full.pdf
Web Search
http://www.bloodjournal.org/content/early/2011/07/15/blood-2
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-04-34
Publisher Site
http://dx.doi.org/10.1182/blood-2011-04-349134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172798PMC
September 2011
15 Reads

Publication Analysis

Top Keywords

flc
19
flc abnormalities
16
flc ratio
12
polyclonal flc
8
prognostic biomarkers
8
chronic lymphocytic
8
normal flc
8
ratio-only flc
8
types flc
8
prognostic utility
8
flc assay
8
flc abnormality
8
abnormal flc
8
lymphocytic leukemia
8
free light
8
monoclonal flc
8
light chains
8
elevated and/or
8
associated poor
8
flc elevated
8

References

(Supplied by CrossRef)
Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell et al.
Clin Chem 2001
Serum reference intervals and diagnostic ranges for free {kappa} and free {lambda} immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann et al.
Clin Chem 2002
Mitogen activation of human chronic lymphatic leukemia cells.
Maino et al.
J Immunol 1977
Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodkgin’s lymphoma.
Gordon et al.
Immunology 1978

Similar Publications